facebooktwittertelegramwhatsapp
copy short urlprintemail
+ A
A -
webmaster

DOHA The Ministry of Public Health (MoPH) has taken steps to withdraw the Lipodar medicine, which is used to reduce cholesterol, from the market. The drug was produced by Dar Al-Dawa Company. This move came following a decision taken by the Gulf Central Committee for Drug Registration since the medicine lacks bio-equivalence with the innovator drug.
copy short url   Copy
23/03/2018
1244